Definition and prevalence
Constipation is described as a decrease in bowel movement frequency, typically defined as fewer than three bowel movements per week, accompanied by symptoms such as hard stools, straining, and a sensation of incomplete evacuation. [1] In the palliative care context, reduced physical activity and medication side effects, particularly from opioids, exacerbate the condition.
Opioid-induced constipation (OIC) is a common side effect of opioid medications, which are frequently used in palliative care for pain management. OIC occurs when opioids bind to mu-opioid receptors in the gastrointestinal (GI) tract, leading to slowed peristalsis, reduced fluid secretion into the intestines, and increased water absorption from the bowel. [2-4] This results in harder stools, less frequent bowel movements, and symptoms such as straining and a feeling of incomplete evacuation. OIC can significantly affect a patient’s quality of life, causing discomfort and distress, which can be particularly challenging in palliative care where maintaining comfort is a priority. OIC affects up to 90% of palliative care patients on opioid therapy. [4] The high rate of OIC underscores the need for proactive management strategies, as untreated constipation can severely impact quality of life.
Assessment
Assessing constipation in palliative care requires a comprehensive approach that combines both objective and subjective evaluations. Objective measures often include bowel movement frequency, stool consistency, and the degree of straining during defecation. Tools such as the Bristol Stool Chart are commonly used to categorise stool types and guide treatment decisions. [3] However, relying solely on these physical indicators may not fully capture the patient’s overall experience, especially in palliative care, where factors like psychological well-being and overall quality of life are also important. [5]
Subjective assessments are valuable for capturing the broader impacts of constipation on patients. Patients may report symptoms such as discomfort, bloating, and emotional distress, which can influence their quality of life. [6] These subjective experiences, however, may be underreported due to factors such as embarrassment or cultural sensitivities, which underscores the need for sensitive communication between healthcare providers and patients. [1]
In cases of severe constipation, faecal impaction can lead to overflow diarrhoea, where liquid stool bypasses the impacted faeces. This complication can sometimes be misinterpreted as diarrhoea but is a sign of significant constipation. [1] Overflow should be suspected in patients presenting with paradoxical loose stools alongside infrequent bowel movements, prolonged periods without defecation, or discomfort. [1,5]
Regular reassessment is recommended because constipation in palliative care patients can vary due to changes in medication, diet, and overall health status. Early identification and routine assessment of OIC can facilitate timely interventions, potentially improving the patient's comfort and quality of life. [2,3]
Non-pharmacological treatment
Non-pharmacological approaches are frequently recommended in palliative care to manage constipation, providing an alternative or complementary strategy to pharmacological treatments. These approaches often include dietary modifications, hydration, physical activity, and alternative therapies, though their application can be inconsistent across care settings. [3,6]
Dietary adjustments, particularly increasing dietary fibre intake, are commonly advised to improve bowel regularity. Fibre can be introduced through food or supplements, and while it is generally effective in promoting bowel movements, its success may depend on the patient’s overall health and mobility. [6] Adequate hydration is another key component, as sufficient fluid intake is essential for softening stools and facilitating regular bowel movements. However, these recommendations must be tailored to the individual, especially in palliative care patients who may be frail or have other medical complications that impact their ability to tolerate increased fibre or fluid intake. [3]
Physical activity, where possible, is also recommended to stimulate bowel function. Even minimal movement, such as gentle exercises or walking, can help reduce the risk of constipation. [3] However, in palliative care settings, many patients have limited mobility, which can reduce the feasibility and effectiveness of physical activity as a treatment option. For these patients, healthcare providers may need to consider other methods to encourage bowel regularity, acknowledging the limitations imposed by the patient’s condition. [6]
Alternative therapies, including massage, reflexology, and acupuncture, have been explored as non-pharmacological interventions for constipation. While the evidence supporting these therapies varies, they are considered beneficial in some cases, particularly when integrated into a comprehensive care plan. [7] For example, abdominal massage has been shown to improve bowel movements and reduce discomfort in certain patients, though its use depends on the patient’s comfort and overall condition. [6,7]
Pharmacological treatment
Pharmaceutical treatments are fundamental in managing constipation in palliative care, particularly due to the prevalence of OIC. The primary pharmaceutical interventions include various types of laxatives, such as stimulant, osmotic, and bulk-forming agents. Laxatives are central to pharmaceutical management, with stimulant laxatives like senna and bisacodyl being commonly used. These agents increase intestinal motility, promoting bowel movements, and are often chosen for their ability to provide rapid relief. [3,8] However, stimulant laxatives can sometimes cause side effects such as abdominal cramps and diarrhoea, making it essential to monitor patients and adjust dosages as needed to balance efficacy and tolerability. [6]
Osmotic laxatives, such as lactulose and polyethylene glycol, are frequently used to soften stools by drawing water into the bowel, which facilitates easier defecation. [4] These laxatives are valued for their effectiveness, although they typically act more slowly than stimulant laxatives, which may influence their use depending on the urgency of symptom relief. [3,6] The decision between osmotic and stimulant laxatives often depends on the patient’s symptoms, urgency of treatment, and overall health status. [6]
Bulk-forming laxatives, such as psyllium, are less commonly utilised in palliative care due to the requirement for adequate hydration and the potential for increased bloating and discomfort. [3] These agents work by absorbing water in the intestines, increasing stool bulk and promoting peristalsis, but their effectiveness may be limited in palliative care patients, especially those with reduced fluid intake or mobility. [6]
Stool softeners, like docusate sodium, are sometimes prescribed to increase the water content of stools, making them easier to pass. [4] However, the effectiveness of stool softeners alone is debated, and they are often used in combination with other laxatives to enhance their overall efficacy. [3]
Pharmaceutical management of constipation in palliative care often requires a personalised approach, combining different classes of medications based on the patient’s symptoms, response to treatment, and overall health status. [6] Regular reassessment is crucial to ensure that the treatment remains effective and to adjust the regimen as the patient’s condition evolves. [2,3]